p.S106L | DO222414 | BTCA | ICGC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.7222 |
p.S106L | DO222414 | BTCA | ICGC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.7222 |
p.V100E | DO234268 | ESAD | ICGC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation altering degron motif | 0.6582 |
p.V100E | DO234268 | ESAD | ICGC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation altering degron motif | 0.6582 |
p.T105A | DO233766 | GACA | ICGC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | DO233766 | GACA | ICGC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00157 | Neuroblastoma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00157 | Neuroblastoma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM01038 | B-Cell Non-Hodgkin's Lymphoma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM01038 | B-Cell Non-Hodgkin's Lymphoma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00592 | Oral Cavity Carcinoma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00592 | Oral Cavity Carcinoma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00278 | Esophageal Squamous Cell Carcinoma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00278 | Esophageal Squamous Cell Carcinoma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00498 | Colorectal Carcinoma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00498 | Colorectal Carcinoma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00612 | Glioma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00612 | Glioma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM01653 | Non-Cancerous | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM01653 | Non-Cancerous | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00397 | Acute Myeloid Leukemia | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00397 | Acute Myeloid Leukemia | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM01735 | Biliary Tract Carcinoma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM01735 | Biliary Tract Carcinoma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM01336 | Glioblastoma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM01336 | Glioblastoma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM01321 | Pancreatic Carcinoma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM01321 | Pancreatic Carcinoma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00015 | Esophageal Squamous Cell Carcinoma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | SIDM00015 | Esophageal Squamous Cell Carcinoma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | KINGS-1 | central nervous system | COSMIC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | KINGS-1 | central nervous system | COSMIC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | HO-1-N-1 | salivary gland | COSMIC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | HO-1-N-1 | salivary gland | COSMIC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | EC-GI-10 | oesophagus | COSMIC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | EC-GI-10 | oesophagus | COSMIC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | KP-N-YS | autonomic ganglia | COSMIC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation blocking phosphorylation signal | 0.75 |
p.T105A | KP-N-YS | autonomic ganglia | COSMIC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation blocking phosphorylation signal | 0.75 |
p.E114Q | DO14566 | HNSC | ICGC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation rewiring degron network | 0.0556 |
p.E114Q | DO14566 | HNSC | ICGC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation rewiring degron network | 0.0556 |
p.P103Q | DO50674 | ORCA | ICGC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation altering degron motif | 0.5924 |
p.P103Q | DO50674 | ORCA | ICGC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation altering degron motif | 0.5924 |
p.R91H | DO33084 | PACA | ICGC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation rewiring degron network | 0.1111 |
p.R91H | DO33084 | PACA | ICGC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation rewiring degron network | 0.1389 |
p.R98L | DO51486 | PACA | ICGC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation altering degron motif | 0.8428 |
p.R112H | SIDM02021 | Esophageal Carcinoma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation rewiring degron network | 0.1111 |
p.R112H | SIDM02021 | Esophageal Carcinoma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation rewiring degron network | 0.1111 |
p.R112H | SIDM00596 | Endometrial Carcinoma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation rewiring degron network | 0.1111 |
p.R112H | SIDM00596 | Endometrial Carcinoma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation rewiring degron network | 0.1111 |
p.R112H | ACH-001517 | Endometrial/Uterine Cancer | CCLE | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation rewiring degron network | 0.1111 |
p.R112H | ACH-001517 | Endometrial/Uterine Cancer | CCLE | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation rewiring degron network | 0.1111 |
p.R112H | HEC-1 | endometrium | COSMIC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation rewiring degron network | 0.1111 |
p.R112H | HEC-1 | endometrium | COSMIC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation rewiring degron network | 0.1111 |
p.R110Q | SIDM00596 | Endometrial Carcinoma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation rewiring degron network | 0.1667 |
p.R110Q | SIDM00596 | Endometrial Carcinoma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation rewiring degron network | 0.1667 |
p.R110Q | ACH-001517 | Endometrial/Uterine Cancer | CCLE | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation rewiring degron network | 0.1667 |
p.R110Q | ACH-001517 | Endometrial/Uterine Cancer | CCLE | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation rewiring degron network | 0.1667 |
p.R110Q | HEC-1 | endometrium | COSMIC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation rewiring degron network | 0.1667 |
p.R110Q | HEC-1 | endometrium | COSMIC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation rewiring degron network | 0.1667 |
p.V100A | SIDM00217 | Colorectal Carcinoma | GDSC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation altering degron motif | 0.5825 |
p.V100A | SIDM00217 | Colorectal Carcinoma | GDSC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation altering degron motif | 0.5825 |
p.V100A | ACH-000999 | Colon/Colorectal Cancer | CCLE | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation altering degron motif | 0.5825 |
p.V100A | ACH-000999 | Colon/Colorectal Cancer | CCLE | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation altering degron motif | 0.5825 |
p.V100A | SNU-1040 | large intestine | COSMIC | LVLYPE | LIG_APCC_ABBA_1 | 99:104 | Mutation altering degron motif | 0.5825 |
p.V100A | SNU-1040 | large intestine | COSMIC | RLVLYPE | LIG_APCC_ABBAyCdc20_2 | 98:104 | Mutation altering degron motif | 0.5825 |